MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Aptinyx Current Ratio 2011-2026 | APTX
Current Ratio Jährlich Aptinyx
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.35 | 5.7 | 32.1 | 20.6 | 24.7 | 20.9 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.1 | 2.35 | 17.7 |
Current Ratio Vierteljährlich Aptinyx
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.61 | 2.35 | 2.78 | 3.06 | 3.66 | 5.7 | 6.44 | 39.3 | 38.7 | 32.1 | 25.8 | 29.6 | 26.1 | 20.6 | 16.2 | 25.4 | 22.4 | 24.7 | 21 | 23.7 | 24.7 | 20.9 | 20.9 | 20.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 39.3 | 1.61 | 19.1 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.84 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
5.42 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
1.43 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
0.796 | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
11.2 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
0.607 | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
1.4 | $ 33.32 | -4.81 % | $ 897 M | USA |
|
Forte Biosciences
FBRX
|
3.8 | $ 22.02 | 0.09 % | $ 285 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
8.41 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
1.88 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
1.59 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
0.826 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
7.95 | $ 92.8 | 2.06 % | $ 22.4 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.73 | 4.85 % | $ 460 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
6.17 | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
1.67 | $ 7.98 | -1.61 % | $ 5.42 B |  Spain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
6.09 | - | -4.36 % | $ 27 M | USA |
 |
Heron Therapeutics
HRTX
|
1.06 | $ 0.87 | 0.41 % | $ 145 M | USA |
 |
Compugen Ltd.
CGEN
|
7.46 | $ 2.79 | 6.9 % | $ 261 M | Israel |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 14.78 | -1.63 % | $ 212 M | USA |
 |
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
Incyte Corporation
INCY
|
3.89 | $ 96.93 | -0.5 % | $ 18.9 B | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.38 | -1.73 % | $ 5.56 M | Israel |
 |
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | Canada |
 |
Coherus BioSciences
CHRS
|
1.31 | $ 1.64 | 4.46 % | $ 192 M | USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
5.43 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 20.79 | -1.05 % | $ 2.65 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |